World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
52367
World Ranking
6685
National Ranking
382

Overview

Martin Dreyling is affiliated with Ludwig-Maximilians-Universität München in Germany. Their research focuses predominantly on medicine, with significant contributions in pathology and forensic medicine, oncology, genetics, immunology, and neurology.

Their main topics of work include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics

Martin Dreyling has published extensively across multiple venues, contributing notably to the following journals:

  • Blood
  • Hematological Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • HemaSphere
  • Journal of Clinical Oncology

They have collaborated frequently with several co-authors including Eva Hoster, Catherine Thiéblemont, Andreas Viardot, Stephen J. Schuster, and Christiane Pott.

Among their recent papers are:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (2022, Blood)
  • Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study (2020, The Lancet Oncology)
  • Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial (2021, Nature Medicine)
  • CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma (2021, Blood)
  • Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma (2022, New England Journal of Medicine)

Best Publications

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

    Wolfgang Hiddemann;Michael Kneba;Martin Dreyling;Norbert Schmitz

  • Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

    Michael L. Wang;Simon Rule;Peter Martin;Andre Goy

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

    Ajay K. Gopal;Ajay K. Gopal;Brad S. Kahl;Sven de Vos;Nina D. Wagner-Johnston

  • A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

    Eva Hoster;Martin Dreyling;Wolfram Klapper;Christian Gisselbrecht

  • The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas : results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

    Roswitha Forstpointner;Martin Dreyling;Roland Repp;Sandra Hermann

  • Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

    Georg Lenz;Martin Dreyling;Eva Hoster;Bernhard Wörmann

  • Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

    Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof

  • Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

    Alessandro Pastore;Vindi Jurinovic;Robert Kridel;Eva Hoster

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  • Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG).

    Roswitha Forstpointner;Michael Unterhalt;Martin Dreyling;Hans-Peter Böck

  • Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M Dreyling;M Ghielmini;S Rule;G Salles

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

    Annina Herrmann;Eva Hoster;Thomas Zwingers;Günter Brittinger

  • Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

    Martin Dreyling;Wojciech Jurczak;Mats Jerkeman;Rodrigo Santucci Silva

  • Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

    Patricia Pérez-Galán;Martin Dreyling;Adrian Wiestner

  • Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma : A systematic review and meta-analysis

    Holger Schulz;Julia F. Bohlius;Sven Trelle;Nicole Skoetz

  • Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

    Anjali Advani;Bertrand Coiffier;Myron S. Czuczman;Martin Dreyling

  • Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.

    Michael L. Wang;Kristie A. Blum;Peter Martin;Andre Goy

Frequent Co-Authors

Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Wolfram Klapper
Wolfram Klapper Kiel University
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna
Michael Hallek
Michael Hallek University of Cologne
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Michael Kneba
Michael Kneba Kiel University
Michael Pfreundschuh
Michael Pfreundschuh Saarland University
Norbert Schmitz
Norbert Schmitz University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary educational pathways can open doors to a wide range of healthcare careers in the USA. For nurses seeking advanced qualifications, there are options like a DNP program without clinical hours, which offers leadership-focused advancement while avoiding the time-intensive clinical requirements.

Those looking to enter the field quickly may consider a lpn program, often available online with accelerated timelines that make it feasible to start working as a Licensed Practical Nurse in less than a year.

Nursing professionals aiming to specialize in mental health can pursue accelerated msn psychiatric np programs, designed to fast-track certification for those wishing to work as Psychiatric Mental Health Nurse Practitioners.

Additionally, students interested in the operational side of healthcare can earn a bachelors in healthcare administration online, providing a flexible pathway into healthcare management, policy, and leadership roles, often at an affordable cost.

Best Scientists Citing Martin Dreyling

Trending Scientists

Recently Published Articles